Potentially harmful excipients in neonatal medicines: a pan-European observational study

Abstract

European neonates receive a number of potentially harmful pharmaceutical excipients. Regional differences in EOI administration suggest that EOI-free products are available and provide the potential for substitution to avoid side effects of some excipients.